Literature DB >> 16766402

Visual recovery following Mycobacterium chelonae endophthalmitis.

Michael W Stewart1, Salvador Alvarez, William W Ginsburg, Rajesh Shetty, Walter C McLain, Joseph P Sleater.   

Abstract

Following uncomplicated cataract surgery, a patient receiving etanercept for psoriatic arthritis developed Mycobacterium chelonae endophthalmitis. Vitrectomy, capsulectomy, and intraocular lens removal was followed by intravitreal amikacin, topical gatifloxacin, intravenous imipenem, and oral clarithromycin for six months. The patient achieved a final corrected visual acuity of 20/20. Etanercept has been implicated in the development of numerous, severe granulomatous infections, though not previously with M. chelonae. This represents the first reported case of visual recovery following M. chelonae endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766402     DOI: 10.1080/09273940600678062

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

Review 1.  Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Rheumatol       Date:  2011-12-15       Impact factor: 2.980

Review 2.  Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature.

Authors:  Wajiha J Kheir; Huda Sheheitli; Maamoun Abdul Fattah; Rola N Hamam
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

Review 3.  Nontuberculous mycobacterial endophthalmitis: case series and review of literature.

Authors:  Warinyupa Pinitpuwadol; Nattaporn Tesavibul; Sutasinee Boonsopon; Darin Sakiyalak; Sucheera Sarunket; Pitipol Choopong
Journal:  BMC Infect Dis       Date:  2020-11-23       Impact factor: 3.090

4.  Recurrent nontuberculous mycobacterial endophthalmitis: a diagnostic conundrum.

Authors:  Nandini Venkateswaran; Gabrielle Yeaney; Mina Chung; Holly B Hindman
Journal:  Clin Ophthalmol       Date:  2014-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.